Cooper Debt to Equity Ratio 2010-2024 | COO
Current and historical debt to equity ratio values for Cooper (COO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cooper debt/equity for the three months ending July 31, 2024 was 0.33.
| Cooper Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-07-31 |
$4.18B |
$7.93B |
0.53 |
| 2024-04-30 |
$4.24B |
$7.80B |
0.54 |
| 2024-01-31 |
$4.34B |
$7.70B |
0.56 |
| 2023-10-31 |
$4.11B |
$7.55B |
0.54 |
| 2023-07-31 |
$4.17B |
$7.53B |
0.55 |
| 2023-04-30 |
$4.16B |
$7.38B |
0.56 |
| 2023-01-31 |
$4.23B |
$7.34B |
0.58 |
| 2022-10-31 |
$4.32B |
$7.18B |
0.60 |
| 2022-07-31 |
$4.47B |
$7.08B |
0.63 |
| 2022-04-30 |
$4.76B |
$7.01B |
0.68 |
| 2022-01-31 |
$4.74B |
$6.93B |
0.68 |
| 2021-10-31 |
$2.66B |
$6.94B |
0.38 |
| 2021-07-31 |
$2.83B |
$6.79B |
0.42 |
| 2021-04-30 |
$2.85B |
$6.16B |
0.46 |
| 2021-01-31 |
$2.93B |
$5.99B |
0.49 |
| 2020-10-31 |
$2.91B |
$3.83B |
0.76 |
| 2020-07-31 |
$2.99B |
$3.76B |
0.80 |
| 2020-04-30 |
$2.88B |
$3.63B |
0.80 |
| 2020-01-31 |
$2.82B |
$3.73B |
0.76 |
| 2019-10-31 |
$2.65B |
$3.63B |
0.73 |
| 2019-07-31 |
$2.56B |
$3.62B |
0.71 |
| 2019-04-30 |
$2.66B |
$3.54B |
0.75 |
| 2019-01-31 |
$2.87B |
$3.43B |
0.84 |
| 2018-10-31 |
$2.81B |
$3.31B |
0.85 |
| 2018-07-31 |
$3.03B |
$3.23B |
0.94 |
| 2018-04-30 |
$3.23B |
$3.19B |
1.01 |
| 2018-01-31 |
$3.11B |
$3.16B |
0.99 |
| 2017-10-31 |
$1.68B |
$3.18B |
0.53 |
| 2017-07-31 |
$1.69B |
$3.09B |
0.55 |
| 2017-04-30 |
$1.81B |
$2.94B |
0.62 |
| 2017-01-31 |
$1.84B |
$2.82B |
0.65 |
| 2016-10-31 |
$1.78B |
$2.70B |
0.66 |
| 2016-07-31 |
$1.86B |
$2.74B |
0.68 |
| 2016-04-30 |
$1.86B |
$2.75B |
0.68 |
| 2016-01-31 |
$1.80B |
$2.61B |
0.69 |
| 2015-10-31 |
$1.79B |
$2.67B |
0.67 |
| 2015-07-31 |
$1.73B |
$2.69B |
0.64 |
| 2015-04-30 |
$1.78B |
$2.62B |
0.68 |
| 2015-01-31 |
$1.82B |
$2.52B |
0.72 |
| 2014-10-31 |
$1.87B |
$2.59B |
0.72 |
| 2014-07-31 |
$0.69B |
$2.68B |
0.26 |
| 2014-04-30 |
$0.66B |
$2.56B |
0.26 |
| 2014-01-31 |
$0.66B |
$2.45B |
0.27 |
| 2013-10-31 |
$0.71B |
$2.42B |
0.30 |
| 2013-07-31 |
$0.57B |
$2.44B |
0.23 |
| 2013-04-30 |
$0.63B |
$2.34B |
0.27 |
| 2013-01-31 |
$0.72B |
$2.25B |
0.32 |
| 2012-10-31 |
$0.73B |
$2.21B |
0.33 |
| 2012-07-31 |
$0.79B |
$2.10B |
0.38 |
| 2012-04-30 |
$0.59B |
$2.04B |
0.29 |
| 2012-01-31 |
$0.66B |
$1.94B |
0.34 |
| 2011-10-31 |
$0.69B |
$1.94B |
0.36 |
| 2011-07-31 |
$0.73B |
$1.89B |
0.39 |
| 2011-04-30 |
$0.82B |
$1.81B |
0.45 |
| 2011-01-31 |
$0.85B |
$1.72B |
0.49 |
| 2010-10-31 |
$0.86B |
$1.67B |
0.52 |
| 2010-07-31 |
$0.91B |
$1.59B |
0.57 |
| 2010-04-30 |
$0.97B |
$1.54B |
0.63 |
| 2010-01-31 |
$0.97B |
$1.55B |
0.63 |
| 2009-10-31 |
$1.01B |
$1.54B |
0.66 |
| 2009-07-31 |
$1.07B |
$1.51B |
0.71 |
| 2009-04-30 |
$1.12B |
$1.43B |
0.78 |
| 2009-01-31 |
$1.17B |
$1.38B |
0.85 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.668B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
